The global synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.
This report analyzes the market for various synthetic biology market and their adoption patterns. It aims at estimating the market size and future growth potential of the synthetic biology market and its subsegments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology are likely to hamper the growth of this market.
The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period
Based on tools, the market has been segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno-nucleic acids, and synthetic cells. In 2019, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period.
This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.
The genome engineering segment is expected to grow at the highest CAGR during the forecast period
On the basis of technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology, bioinformatics technologies.
The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.
The industrial applications segment is expected to grow at the highest CAGR during the forecast period
Based on application, the synthetic biology market is segmented into medical, industrial, food & agricultural, and environmental applications. The industrial applications segment is expected to grow at the highest CAGR owing to the rising applications of synthetic biology in producing renewable energy, biomaterials & green chemicals, and enzymes.
The Asia Pacific is projected to witness the highest growth during the forecast period
The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the synthetic biology market.
However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support.
Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.
Key Topics Covered
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Market Overview 4.2 Asia Pacific: Market, By Application 4.3 Market: Geographic Growth Opportunities 4.4 Market, By Region (2018-2025) 4.5 Market: Developed vs. Developing Markets
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 22.214.171.124 Wide Range of Applications of Synthetic Biology 126.96.36.199 Rising R&D Funding and Growing Initiatives in Synthetic Biology 188.8.131.52 Declining Cost of DNA Sequencing and Synthesizing 184.108.40.206 Increasing Investments in the Market 5.2.2 Restraints 220.127.116.11 Biosafety, Biosecurity, and Ethical Concerns 5.2.3 Opportunities 18.104.22.168 Rising Need for Fuel Alternatives 22.214.171.124 Increasing Demand for Protein Therapeutics and Personalized Medicine 126.96.36.199 Increasing Research in Synthetic Drugs and Vaccines 5.2.4 Challenges 188.8.131.52 Standardization of Biological Parts
6 Synthetic Biology Market, By Tool 6.1 Introduction 6.2 Oligonucleotides & Synthetic DNA 6.2.1 Oligonucleotides and Synthetic Dna to Dominate the Market During the Forecast Period 6.3 Enzymes 6.3.1 Development of Enzymes has Helped in Evolving New Therapies for A Range of Diseases 6.4 Cloning Technology Kits 6.4.1 Need for the Creation of Artificial Dna Along With Their Assembly is Driving the Growth of the Segment 6.5 Synthetic Cells 6.5.1 Synthetic Cells Will Allow Tailoring Biologics and Its Adoption is Expected to Grow in the Coming Years 6.6 Chassis Organisms 6.6.1 Increasing Demand for Fossil Fuels is Likely to Propel the Demand for Chassis Organisms 6.7 Xeno-Nucleic Acids 6.7.1 Xnas are Increasingly Researched With the Growing Demand for Breakthrough Medicine
7 Synthetic Biology Market, By Technology 7.1 Introduction 7.2 Gene Synthesis 7.2.1 Gene Synthesis to Dominate the Market During the Forecast Period 7.3 Genome Engineering 7.3.1 Increasing Demand for Synthetic Dna and Genes is Expected to Drive Market Growth 7.4 Sequencing 7.4.1 Ngs Technology is Rapidly Becoming an Indispensable and Universal Tool for Biological Research 7.5 Bioinformatics 7.5.1 Use of Bioinformatics Technologies is Increasing With the Rising Need for Data Management and Curation 7.6 Cloning 7.6.1 Cloning Aids in Building New Genetic Modules/Pathways, Enabling Rapid Advances in Research Across Various Industries 7.7 Site-Directed Mutagenesis 7.7.1 Wide Applications in Genetic Engineering, Dna Assembly, and Cloning Technologies is Driving This Segment 7.8 Measurement & Modeling 7.8.1 Computational Modeling is Aiding the Growth of the Segment During the Forecast Period 7.9 Microfluidics 7.9.1 Droplet Microfluidics is Gaining Wide Recognition in the Field of Synthetic Biology 7.1 Nanotechnology 7.10.1 Convergence Between Synthetic Biology and Nanotechnologies Aid in Building Complex Bodies
8 Synthetic Biology Market, By Application 8.1 Introduction 8.2 Medical Applications 8.2.1 Pharmaceuticals 184.108.40.206 In 2019, the Pharmaceuticals Segment Accounted for the Largest Share of the Medical Applications Market 8.2.2 Drug Discovery and Therapeutics 220.127.116.11 Cancer Detection & Diagnostics 18.104.22.168.1 With Rising Investments for Cancer Research, the Market for Synthetic Biology is Expected to Grow for This Segment 22.214.171.124 Other Drug Discovery and Therapeutic Applications 8.2.3 Artificial Tissue & Tissue Regeneration 126.96.36.199 Bio-Synthesis 188.8.131.52.1 Bio-Synthesis is Dominating the Market With Its Increasing Adoption in Creating Artificial Genomes 184.108.40.206 Stem Cell Regulation 220.127.116.11.1 Use of Synthetic Biology in Stem Cell Regeneration and Reprogramming Somatic Cells is Expected to Drive Market Growth 18.104.22.168 Other Artificial Tissue and Tissue Regeneration Applications 8.3 Industrial Applications 8.3.1 Biofuel and Renewable Energy 22.214.171.124 Advantages of Using Genetically Engineered Organisms for the Synthetic Production of Biofuels is Driving Market Growth 8.3.2 Industrial Enzymes 126.96.36.199 Textile Industry 188.8.131.52.1 Synthetic Biology is Being Applied in the Textile Industry to Replace Traditional Raw Materials 184.108.40.206 Paper Industry 220.127.116.11.1 Enzymes are Being Increasingly Used in the Pulp and Paper Industry 18.104.22.168 Other Industries 8.3.3 Biomaterials & Green Chemicals 22.214.171.124 Silk-Based Proteins are A Type of Biomaterial Prepared Through Synthetic Biology 8.4 Food & Agriculture 8.4.1 Synthetic Biology Techniques are Applied in the Food and Agriculture Industry to Produce Metabolites, Health Products, and Processing Aids 8.5 Environmental Applications 8.5.1 Bioremediation 126.96.36.199 Owing to the Growing Severity of Environmental Problems, It has Become Necessary to Develop Cost-Effective, On-Site Methods for Environmental Monitoring and Bioremediation 8.5.2 Biosensing 188.8.131.52 Biosensor Applications Commonly Make Use of Microalgae Owing to Their High Reproductive Rates and Ease of Culturing Due to Their Microscopic Size
9 Synthetic Biology Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 184.108.40.206 The US Dominates the North American Market 9.2.2 Canada 220.127.116.11 Strong Research Infrastructure and Availability of Funding Will Support Market Growth 9.3 Europe 9.3.1 UK 18.104.22.168 The UK Holds the Largest Share of the European Market 9.3.2 Germany 22.214.171.124 The Rapidly Growing Pharmaceutical Market is Expected to Drive Market Growth 9.3.3 France 126.96.36.199 Research Across All Industries is Strongly Supported By the Government 9.3.4 Denmark 188.8.131.52 Denmark has the Third-Largest Commercial Drug-Development Pipeline in Europe 9.3.5 Switzerland 184.108.40.206 Market Growth is Primarily Driven By the Well-Established Pharmaceutical & Biotechnology Industry in the Country 9.3.6 Spain 220.127.116.11 Spain has A Well-Established Network of Research Centers, Universities, and Hospitals, Which Form an Ideal Environment for Research 9.3.7 Italy 18.104.22.168 Growth in This Market is Mainly Driven By Increasing Life Science R&D in the Country, Funded By Both Public and Private Organizations 9.3.8 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 22.214.171.124 Large Number of Research Initiatives Towards the Development of Precision Medicine Supporting Market Growth 9.4.2 China 126.96.36.199 Growth in R&D to Enhance the Technological Capabilities in the Country, Thereby Driving the Demand for High-Quality Research Tools 9.4.3 Australia 188.8.131.52 Increasing Focus of the Healthcare System on Precision Medicine to Offer Significant Growth Opportunities 9.4.4 India 184.108.40.206 Increasing Pharma R&D and Government Funding in the Biotechnology Industry are the Major Factors Driving Market Growth 9.4.5 Rest of Asia Pacific 9.5 Latin America 9.5.1 Strong Pharmaceutical Industry in the Region to Provide Significant Growth Opportunities 9.6 Middle East and Africa 9.6.1 Increasing Partnerships Among Global Players With Government Organizations in the Region to Support Growth